VALAMOR
LIVE

Serial Number

79201384

Owner

NOVARTIS AG

Filing Date

Dec 12, 2016

Add to watchlist:

No watchlists yet
View on USPTO

VALAMOR Trademark

Serial Number: 79201384 • Registration: 5220587

VALAMOR is a trademark filed by NOVARTIS AG on December 12, 2016. The trademark is classified under Class 5 (Pharmaceuticals). The application is currently registered and active.

Owner Contact Info

NOVARTIS AG (7,171 trademarks)

CH-4002
BASEL , CH

Entity Type: 03

Trademark Details

Filing Date

December 12, 2016

Registration Date

June 13, 2017

Published for Opposition

March 28, 2017

Cancellation Date

December 16, 2016

Goods & Services

Anti-infectives; anti-inflammatories; antibacterial pharmaceuticals; antibiotics; antifungal preparations; antivirals; cardiovascular pharmaceuticals; dermatological pharmaceutical preparations; inhaled pharmaceutical preparations for the prevention and treatment of respiratory diseases and disorders; pharmaceutical preparations acting on the central nervous system; pharmaceutical preparations and substances for the prevention and treatment of gastrointestinal diseases; pharmaceutical preparations for the prevention and treatment of diseases and disorders of the autoimmune system, the metabolic system, the endocrine system, the musculoskeletal system and the genitourinary system; pharmaceutical preparations for use in hematology and in tissue and organ transplantation; pharmaceutical preparations for the prevention and treatment of eye diseases and conditions; pharmaceutical preparations for the prevention and treatment of heart rhythm disorders; pharmaceutical preparations for the prevention and treatment of immune system related diseases and disorders; pharmaceutical preparations for the prevention and treatment of kidney diseases; pharmaceutical preparations for the prevention and treatment of diabetes; pharmaceutical preparations for the prevention and treatment of hypertension; pharmaceutical preparations for the prevention and treatment of skin disorders; pharmaceutical preparations for use in dermatology; pharmaceutical preparations for use in urology; pharmaceutical preparations for ophthalmological use; pharmaceutical preparations for the prevention and treatment of cancer and tumors; pharmaceutical preparations for the prevention and the treatment of allergies; pharmaceutical preparations for the prevention and treatment of bone diseases; pharmaceutical preparations for the prevention and treatment of respiratory diseases and asthma

Filing History

NOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG MAILED
Oct 11, 2018 DENC
DEATH OF INTERNATIONAL REGISTRATION
Oct 11, 2018 DETH
NOTIFICATION PROCESSED BY IB
Oct 6, 2017 GPNX
FINAL DISPOSITION NOTICE SENT TO IB
Jul 19, 2017 FICS
FINAL DISPOSITION PROCESSED
Jul 19, 2017 FIMP
GRANT OF PROTECTION CREATED, TO BE SENT TO IB
Jul 13, 2017 GPAR
REGISTERED-PRINCIPAL REGISTER
Jun 13, 2017 R.PR
PUBLISHED FOR OPPOSITION
Mar 28, 2017 PUBO
NOTICE OF PUBLICATION
Mar 8, 2017 NPUB
APPLICATION FILING RECEIPT MAILED
Feb 17, 2017 MAFR
APPROVED FOR PUB - PRINCIPAL REGISTER
Feb 16, 2017 CNSA
ASSIGNED TO EXAMINER
Feb 16, 2017 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Feb 13, 2017 NWOS
LIMITATION FROM ORIGINAL APPLICATION ENTERED
Feb 10, 2017 LIMI
SN ASSIGNED FOR SECT 66A SUBSEQ DESIG FROM IB
Feb 9, 2017 SDRC